| Announce Date | 08/05/2025 |
| EPS Normalized Actual | $0.99 (Miss by $-0.11) |
| EPS GAAP Actual | $0.99 (Miss by $-0.11) |
| Revenue Actual | $0.333936B |
| Revenue Surprise | Beat by $333.936M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.00633 |
| EPS GAAP Estimate | $2.00633 |
| Revenue Estimate | $0.4450636B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 6.34 | 14.06 | 6.24401 | 6.42818 | 1 |
| Dec 2026 | 6.385 | 13.96 | 6.29 | 6.48 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.9962 | -0.30047 | 0.333936B | -2.48% | -35.4M |
| FQ1 2025 (Mar 2025) | 1.32 | 1.32 | 0.338819B | 4.38% | 338.82M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.361504B | 373.56% | 361.5M |
| FQ3 2024 (Sep 2024) | 3.14 | 3.14 | 0.424629B | 13.34% | 424.63M |
| FQ2 2024 (Jun 2024) | 1.91 | 1.91 | 0.342229B | 9.64% | 342.23M |
| FQ1 2024 (Mar 2024) | 2.19 | 2.19 | 0.323963B | 3.78% | 323.96M |
| FQ4 2023 (Dec 2023) | -0.0044 | -0.0044 | -0.988936B | 131.43% | -988.94M |
| FQ3 2023 (Sep 2023) | 2.71 | 2.71 | 0.367969B | 23.78% | 367.97M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.00633
Consensus Revenue Estimates
0.4450636B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.87 | -- | 0.81771 | 0.90536 | 1 |
| FQ3 2027 (Sep 2027) | 2.43 | -- | 2.42148 | 2.44095 | 1 |
| FQ2 2027 (Jun 2027) | 1.47 | -- | 1.46485 | 1.47663 | 1 |
| FQ1 2027 (Mar 2027) | 1.47 | -- | 1.46485 | 1.47663 | 1 |
| FQ4 2026 (Oct 2026) | 2.15 | -- | 2.09385 | 2.24713 | 1 |
| FQ3 2026 (Jul 2026) | 1.56 | -- | 1.51926 | 1.63047 | 1 |
| FQ2 2026 (Jun 2026) | 1.56 | 36.14 | 1.53094 | 1.58805 | 0 |
| FQ1 2026 (Mar 2026) | 2.04 | 35.29 | 2.002 | 2.07668 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.42B | -- | 0.4B | 0.44B | 2 |
| FQ3 2027 (Sep 2027) | 0.5B | -- | 0.5B | 0.5B | 2 |
| FQ2 2027 (Jun 2027) | 0.4B | -- | 0.39B | 0.4B | 2 |
| FQ1 2027 (Mar 2027) | 0.37B | -- | 0.36B | 0.37B | 2 |
| FQ4 2026 (Oct 2026) | 0.49B | -- | 0.48B | 0.51B | 2 |
| FQ3 2026 (Jul 2026) | 0.42B | -- | 0.41B | 0.44B | 2 |
| FQ2 2026 (Jun 2026) | 0.41B | 17.61 | 0.4B | 0.41B | 1 |
| FQ1 2026 (Mar 2026) | 0.41B | 17.84 | 0.41B | 0.42B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.29667 | 0.9962 | -0.30047 | -30.16% |
| FQ1 2025 (Mar 2025) | 1.32 | 1.32 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 3.14 | 3.14 | 100% | |
| FQ2 2024 (Jun 2024) | 1.91 | 1.91 | 100% | |
| FQ1 2024 (Mar 2024) | 2.19 | 2.19 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0044 | -0.0044 | 100% | |
| FQ3 2023 (Sep 2023) | 2.71 | 2.71 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.37B | $0.33B | $-35.4M | -10.6% |
| FQ1 2025 (Mar 2025) | $0B | $0.34B | $338.82M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.36B | $361.5M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.42B | $424.63M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.34B | $342.23M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.32B | $323.96M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $-0.99B | $-988.94M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0.37B | $367.97M | 100% |